Institute of Experimental Physiology (IFISE-CONICET), National University of Rosario, 2000 Rosario, Argentina.
Institute of Experimental Physiology (IFISE-CONICET), National University of Rosario, 2000 Rosario, Argentina.
Life Sci. 2024 Sep 1;352:122839. doi: 10.1016/j.lfs.2024.122839. Epub 2024 Jun 13.
Estradiol 17β-d-glucuronide (E17G) induces cholestasis by triggering endocytosis and further intracellular retention of the canalicular transporters Bsep and Mrp2, in a cPKC- and PI3K-dependent manner, respectively. Pregnancy-induced cholestasis has been associated with E17G cholestatic effect, and is routinely treated with ursodeoxycholic acid (UDCA). Since protective mechanisms of UDCA in E17G-induced cholestasis are still unknown, we ascertained here whether its main metabolite, tauroursodeoxycholate (TUDC), can prevent endocytosis of canalicular transporters by counteracting cPKC and PI3K/Akt activation.
Activation of cPKC and PI3K/Akt was evaluated in isolated rat hepatocytes by immunoblotting (assessment of membrane-bound and phosphorylated forms, respectively). Bsep/Mrp2 function was quantified in isolated rat hepatocyte couplets (IRHCs) by assessing the apical accumulation of their fluorescent substrates, CLF and GS-MF, respectively. We also studied, in isolated, perfused rat livers (IPRLs), the status of Bsep and Mrp2 transport function, assessed by the biliary excretion of TC and DNP-SG, respectively, and Bsep/Mrp2 localization by immunofluorescence.
E17G activated both cPKC- and PI3K/Akt-dependent signaling, and pretreatment with TUDC significantly attenuated these activations. In IRHCs, TUDC prevented the E17G-induced decrease in apical accumulation of CLF and GS-MF, and inhibitors of protein phosphatases failed to counteract this protection. In IPRLs, E17G induced an acute decrease in bile flow and in the biliary excretion of TC and DNP-SG, and this was prevented by TUDC. Immunofluorescence studies revealed that TUDC prevented E17G-induced Bsep/Mrp2 endocytosis.
TUDC restores function and localization of Bsep/Mrp2 impaired by E17G, by preventing both cPKC and PI3K/Akt activation in a protein-phosphatase-independent manner.
雌二醇 17β-d-葡糖苷酸(E17G)通过触发 Bsep 和 Mrp2 分别以 cPKC 和 PI3K 依赖性方式的内吞作用和进一步的细胞内滞留,诱导胆汁淤积。妊娠引起的胆汁淤积与 E17G 的胆汁淤积作用有关,常规用熊去氧胆酸(UDCA)治疗。由于 UDCA 在 E17G 诱导的胆汁淤积中的保护机制尚不清楚,我们在这里确定其主要代谢物牛磺熊去氧胆酸(TUDC)是否可以通过拮抗 cPKC 和 PI3K/Akt 激活来防止胆小管转运蛋白的内吞作用。
通过免疫印迹法(分别评估膜结合和磷酸化形式)评估分离的大鼠肝细胞中 cPKC 和 PI3K/Akt 的激活。通过评估其荧光底物 CLF 和 GS-MF 在分离的大鼠肝细胞对体(IRHCs)中的顶端积累,分别定量 Bsep/Mrp2 功能。我们还在分离灌注大鼠肝脏(IPRLs)中研究了 Bsep 和 Mrp2 转运功能的状态,分别通过 TC 和 DNP-SG 的胆汁排泄来评估,以及通过免疫荧光法评估 Bsep/Mrp2 的定位。
E17G 激活了 cPKC 和 PI3K/Akt 依赖性信号通路,而 TUDC 预处理可显著减弱这些激活作用。在 IRHCs 中,TUDC 可防止 E17G 诱导的 CLF 和 GS-MF 顶端积累减少,而蛋白磷酸酶抑制剂不能拮抗这种保护作用。在 IPRLs 中,E17G 诱导胆汁流量和 TC 和 DNP-SG 的胆汁排泄急性减少,而 TUDC 可预防这种情况。免疫荧光研究表明,TUDC 可防止 E17G 诱导的 Bsep/Mrp2 内吞作用。
TUDC 通过以蛋白磷酸酶独立的方式防止 cPKC 和 PI3K/Akt 的激活,恢复了 E17G 受损的 Bsep/Mrp2 的功能和定位。